Client News
ViGeneron announces closing of series A financing to drive development of next generation gene
Proteros, co-founder of Rodin Therapeutics, announces Rodin’s acquisition by Alkermes
Vivoryon Therapeutics Reports Third Quarter 2019
American Depositary Shares (“ADS”) Program and Warrant Agent Agreement
Motif Bio plc Announces Voluntary Delisting from the Nasdaq Capital Market
Newron Receives Second Tranche from Financing Agreement with European Investment Bank (EIB)
Expedeon to Present at the Deutsches Eigenkapitalforum in Frankfurt / Main
Vivoryon Therapeutics AG to Publish Third Quarter 2019 Results on November 28, 2019
Motif Bio plc: Directorate Changes